Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: 3D Medicines, Alphamab, Apollomics, Eisai, Eli Lilly, Innovation, Lupin, Moderna, Roche, Shionogi, Samsung Bioepis, Sorrento, Tracon, Vasomune.